Improved Antimicrobial Activity of Linezolid against Vancomycin-Intermediate Staphylococcus aureus-Reference-Cited by-同舟云学术

Improved Antimicrobial Activity of Linezolid against Vancomycin-Intermediate Staphylococcus aureus

Published:2008-11 Issue:11 Volume:52 Page:4207-4208
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Watanabe Yukiko¹,Neoh Hui-min¹,Cui Longzhu¹,Hiramatsu Keiichi¹

Affiliation:

1. Department of Bacteriology  Faculty of Medicine  Juntendo University  2-1-1 Hongo, Bunkyo-Ku  Tokyo, Japan 113-8421

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00676-08

Reference12 articles.

1. Asada, K., Y. Inaba, E. Tateda-Suzuki, K. Kuwahara-Arai, T. Ito, and K. Hiramatsu. 1995. Evolution and resistance expression of MRSA. Evaluation of beta-lactam antibiotics against a set of isogenic strains with different types of phenotypic expression. Acta Biochim. Pol.42:517-524.

2. Cui, L., and K. Hiramatsu. 2003. Vancomycin-resistant Staphylococcus aureus, p. 187-212. In A. C. Fluit and F. J. Schmitz (ed.), MRSA: current perspectives. Caister Academic Press, Norfolk, England.

3. Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus

4. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

5. Diekema, D. J., and R. N. Jones. 2001. Oxazolidinone antibiotics. Lancet358:1975-1982.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus;Antimicrobial Agents and Chemotherapy;2017-11

2. Clinical and Microbiologic Analysis of the Risk Factors for Mortality in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bacteremia;Antimicrobial Agents and Chemotherapy;2015-04-06

3. Vancomycin-intermediate resistance in Staphylococcus aureus;Journal of Global Antimicrobial Resistance;2014-12

4. In Vitro Activity of Novel Oxazolidinone Analogs and 13 Conventional Antimicrobial Agents against Clinical Isolates of Staphylococcus aureus in Beijing, China;Japanese Journal of Infectious Diseases;2014

5. In vitro activities of ceftobiprole, dalbavancin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus blood isolates: stratified analysis by vancomycin MIC;Diagnostic Microbiology and Infectious Disease;2012-07